Coriolus-MRL 500mg 90 tablets
Coriolus-MRL 500mg 90 tablets
Coriolus
Mycology Research Laboratories Ltd.'s Coriolus versicolor
powder contains both mycelium and primordia (young fruit body) cultivated into
a biomass that is grown on a sterilised (autoclaved) substrate.
Mycelium biomass of mushrooms offers a mixture of many co-operating and co-related healthy bioavailable ingredients prepared by nature itself – it is thus a truly pure natural product.
Mushrooms spend more than 90% of their life cycle in the mycelium. Since mushrooms cannot produce their own energy through photosynthesis, the mycelium must be able to actively obtain or produce extracellular compounds and metabolites that promote the longevity and vitality of the living mushroom. These properties lie behind the high enzymatic activity of the mycelium, which stays preserved in the carefully processed MRL products.
Manufacturing Process of Coriolus-MRL™
The Coriolus versicolor is processed under the same
rigorously controlled conditions that are applied to the manufacture of a
conventional pharmaceutical. This ensures that each tablet contains 500 mg of
the standardised Coriolus versicolor product.
The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.
After passing quality control testing, the tablets are released for use. The choice of additives used in manufacturing renders these tablets suitable for Kosher or vegetarian use.
Certified Organic
The fungal biomass Coriolus versicolor that comprises
Coriolus-MRL is certified 100% Organic in the United States by the Quality
Assurance International.
Chemical and Biological Properties *
Each Tablet of Coriolus-MRL contains:
Coriolus versicolor - biomass powder 500 mg
Other ingredients
Microcrystalline Cellulose
Silica
Vegetable Magnesium Sterate
Coriolus-MRL-(in vitro Enzyme Activity) per 725 mg Tablet
Protein content 17.3
mg
Reducing sugars 14.8
mg
Protein-bound polysaccharide 91.5
mg
Glucose 2-oxidase activity 49.5
mU
Peroxidase activity 67.2
mU
Laccase activity 521.5
mU
Glucoamylase / glucansase activity 6.9 U
Superoxide dismutase (SOD) activity 77.1 mU
Cytochrome P-450 0.51
nmoles
Cytochrome P-450 reductase 11.9
mU
Secondary metabolites (Thrombin inhibitors) 59%